The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection (Q40402518)
Jump to navigation
Jump to search
scientific article published on 20 December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection |
scientific article published on 20 December 2016 |
Statements
1 reference
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection (English)
1 reference
William F Balistreri
1 reference
Karen F Murray
1 reference
Philip Rosenthal
1 reference
Sanjay Bansal
1 reference
Chuan-Hao Lin
1 reference
Kathryn Kersey
1 reference
Benedetta Massetto
1 reference
Yanni Zhu
1 reference
Bittoo Kanwar
1 reference
Polina German
1 reference
Evguenia Svarovskaia
1 reference
Diana M Brainard
1 reference
Jessica Wen
1 reference
Regino P Gonzalez-Peralta
1 reference
Maureen M Jonas
1 reference
Kathleen Schwarz
1 reference
20 December 2016
1 reference
1 reference
Identifiers
1 reference